检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵明东[1] 胡雪梅[2] 郝国峰[1] 刘元伟[1] 冯秀栓[1]
机构地区:[1]滨州医学院附属医院放射科,256600 [2]滨州医学院免疫学教研室
出 处:《肿瘤研究与临床》2006年第4期225-227,共3页Cancer Research and Clinic
基 金:山东省教育厅科技发展计划基金资助(J02K12)
摘 要:目的探索原发性肝癌介入治疗前后尿激酶型纤溶酶原激活剂(uPA)及其受体(uPAR)表达的变化,分析uPA及uPAR在人类原发性肝癌发生发展中的作用,并为uPA及uPAR表达水平对介入治疗原发性肝癌的效果评价价值提供可靠的理论依据。方法对48例已确诊的原发性肝癌患者在介入治疗前后分别取静脉血、癌组织和肝正常区组织标本,应用ELISA、RT-PCR方法,分别检测介入治疗前后uPA/uPAR在血清、肝癌组织与正常肝组织中的表达变化。结果介入治疗前uPA/uPAR在血清内的表达量明显高于对照组,两组间的差异有统计学意义(P<0.01);肝癌组织中uPA/uPARmRNA明显高于正常区肝组织,两组间的差异有统计学意义(P<0.01),且介入治疗后肝癌组织中uPA/uPARmRNA的表达量较治疗前明显降低,两组间的差异有统计学意义(P<0.05),但未降至正常。结论uPA/uPAR的过量表达与原发性肝癌的发生有关,uPA/uPAR的mRNA表达水平对介入治疗原发性肝癌的效果评价有一定的参考价值。Objective To study the effects on the expression of uPA / uPAR before and after the interventional therapy of primary hepatocellular carcinoma and analyse the function of the expression of uPA / uPAR on the carcinogenesis and development of primary hepatocellular carcinoma., so as to provide a standard to evaluate the effects on the interventional therapy of primary hepatocellular carcinoma. Methods To analyze the uPA / uPAR in sera of control and patients with ELISA. The mRNA expression levels of uPA / uPAR were assessed by RT-PCR method in the hepatocellular carcinoma tissues and tumor free tissues from 48 patients with primary hepatocellular carcinoma before and after the interventional therapy. Tissue specimens were obtained by biopsy, and confirmed by histological evaluation. Results The uPA / uPAR in patients sera before interventional therapy were higher than those in control group (P 〈0.01). The mRNA levels of uPA / uPAR were increased in hepatocellular carcinoma tissues compared with normal tissues from tumor free tissues (P 〈0.01) and significantly decreased after the interventional therapy(P 〉0.05). Conclusions The overexpression of uPA / uPAR are of great significance in the carcinogenesis and development of gastric carcinoma, might be used as a standard to evaluate the effects on the interventional therapy of primary hepatocellular carcinoma.
关 键 词:肝癌 介入治疗 尿激酶型纤溶酶原激活剂 尿激酶型纤溶酶原激活剂受体
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15